• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    • Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in a regional hepatology center

    Author(s)
    Wickremeratne, T
    Turner, S
    Leschke, P
    Langton, J
    Johnston, S
    Mitchell, J
    O'Beirne, J
    Griffith University Author(s)
    Leschke, Paul
    Year published
    2019
    Metadata
    Show full item record
    Abstract
    Background and Aim: Transjugular intrahepatic portosystemic shunt (TIPS) is an established therapeutic option for treating complications of portal hypertension, including refractory ascites and variceal bleeding. Despite its proven efficacy, TIPS is underused in the majority of hospitals that provide care to patients with chronic liver disease and, in Australia, is largely limited to metropolitan liver units, often liver transplant centers. Patients in regional centers are potentially disadvantaged by limited access to this procedure, particularly as the burden of cirrhosis continues to grow. We evaluated the experience of ...
    View more >
    Background and Aim: Transjugular intrahepatic portosystemic shunt (TIPS) is an established therapeutic option for treating complications of portal hypertension, including refractory ascites and variceal bleeding. Despite its proven efficacy, TIPS is underused in the majority of hospitals that provide care to patients with chronic liver disease and, in Australia, is largely limited to metropolitan liver units, often liver transplant centers. Patients in regional centers are potentially disadvantaged by limited access to this procedure, particularly as the burden of cirrhosis continues to grow. We evaluated the experience of a single regional Australian institute with regard to TIPS, exploring the indications and clinical outcomes, and comparing our data with those reported by larger Australian institutions. Methods: A retrospective analysis was conducted of patients treated with TIPS at a single regional hepatology unit in Queensland between January 2017 and December 2018. Comparison of pre- and post-TIPS data were conducted using the Wilcoxon signed rank test. Results: Ten patients underwent TIPS during this period (Table 1). There was a significant reduction in median portosystemic gradient after TIPS from 14 mmHg (IQR, 11.5–18) to 6 mmHg (IQR, 2–9.2) (P = 0.004). In patients who underwent TIPS for refractory ascites (n = 4), the median number of paracenteses undertaken per patient reduced from 14 (4–16) in the year before TIPS to 1.5 (0–3.75) after TIPS (P = 0.125). At the time of the last follow up, no patient had an ongoing requirement for paracentesis, and 75% of patients achieved freedom from diuretics. In patients who received TIPS for treatment or secondary prevention of variceal bleeding (n = 5), 100% of patients achieved freedom from variceal rebleeding, and no further endoscopic procedures were required for this indication (Fig. 1). Twenty percent of patients developed medically managed hepatic encephalopathy. There were no deaths or hepatic decompensation. There was a dramatic reduction in hospital admission days for complications of cirrhosis, from a total of 154 days before TIPS to 17 days after TIPS (P = 0.02). This was associated with significant cost savings for our unit. Clinical outcomes from our unit were comparable to those in published data from larger Australian centers, with no increase in adverse events. Conclusion: TIPS can be performed successfully and safely in regional centers, with outcomes comparable to those in large metropolitan liver units.
    View less >
    Conference Title
    Journal of Gastroenterology and Hepatology
    Volume
    34
    Issue
    S2
    DOI
    https://doi.org/10.1111/jgh.14799
    Subject
    Clinical sciences
    Science & Technology
    Life Sciences & Biomedicine
    Gastroenterology & Hepatology
    Publication URI
    http://hdl.handle.net/10072/393247
    Collection
    • Conference outputs

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander